Page last updated: 2024-11-05

tranexamic acid and Systemic Inflammatory Response Syndrome

tranexamic acid has been researched along with Systemic Inflammatory Response Syndrome in 2 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Systemic Inflammatory Response Syndrome: A systemic inflammatory response to a variety of clinical insults, characterized by two or more of the following conditions: (1) fever

Research Excerpts

ExcerptRelevanceReference
"Whereas in DIC associated with trauma, since balance between coagulation and fibrinolysis collapses drastically in a short period, both anticoagulantion therapy and antifibrinolytic therapy can be utilized depending on clinical conditions."2.53[Anti DIC therapy]. ( Sakamoto, Y; Yahata, M, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Changjun, C1
Xin, Z1
Yue, L1
Chengcheng, Z1
Qiuru, W1
Qianhao, L1
Pengde, K1
Yahata, M1
Sakamoto, Y1

Reviews

1 review available for tranexamic acid and Systemic Inflammatory Response Syndrome

ArticleYear
[Anti DIC therapy].
    Nihon rinsho. Japanese journal of clinical medicine, 2016, Volume: 74, Issue:2

    Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzamidines; Disseminated Intravascular Coa

2016

Trials

1 trial available for tranexamic acid and Systemic Inflammatory Response Syndrome

ArticleYear
Tranexamic acid attenuates early post-operative systemic inflammatory response and nutritional loss and avoids reduction of fibrinogen in total hip arthroplasty within an enhanced recovery after surgery pathway.
    International orthopaedics, 2021, Volume: 45, Issue:11

    Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Enhanced Recovery Aft

2021
chemdatabank.com